Cargando…
The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model
OBJECTIVES: To determine whether nalmefene combined with psychosocial support is cost-effective compared with psychosocial support alone for reducing alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels (DRLs) as defined by the WHO, and to evaluate the public he...
Autores principales: | Laramée, Philippe, Brodtkorb, Thor-Henrik, Rahhali, Nora, Knight, Chris, Barbosa, Carolina, François, Clément, Toumi, Mondher, Daeppen, Jean-Bernard, Rehm, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166142/ https://www.ncbi.nlm.nih.gov/pubmed/25227627 http://dx.doi.org/10.1136/bmjopen-2014-005376 |
Ejemplares similares
-
Clinical relevance of nalmefene versus placebo in alcohol treatment: Reduction in mortality risk
por: Roerecke, Michael, et al.
Publicado: (2015) -
Modelling the consequences of a reduction in alcohol consumption among patients with alcohol dependence based on real-life observational data
por: Rahhali, Nora, et al.
Publicado: (2015) -
Impact of low and no alcohol beers on purchases of alcohol: interrupted time series analysis of British household shopping data, 2015–2018
por: Anderson, Peter, et al.
Publicado: (2020) -
Socioeconomic determinants of risk of harmful alcohol drinking among people aged 50 or over in England
por: Iparraguirre, José
Publicado: (2015) -
Real-time patterns of smoking and alcohol use: an observational study protocol of risky-drinking smokers
por: Cohn, Amy, et al.
Publicado: (2015)